UBS Group’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $199M | Buy |
|
|||||
|
2025
Q2 | $169M | Sell |
|
|||||
|
2025
Q1 | $136M | Buy |
|
|||||
|
2024
Q4 | $151M | Buy |
|
|||||
|
2024
Q3 | $94.7M | Buy |
|
|||||
|
2024
Q2 | $136M | Buy |
|
|||||
|
2024
Q1 | $154M | Buy |
|
|||||
|
2023
Q4 | $128M | Sell |
|
|||||
|
2023
Q3 | $100M | Buy |
|
|||||
|
2023
Q2 | $122M | Buy |
|
|||||
|
2023
Q1 | $71M | Sell |
|
|||||
|
2022
Q4 | $75.4M | Buy |
|
|||||
|
2022
Q3 | $28.1M | Sell |
|
|||||
|
2022
Q2 | $32.9M | Sell |
|
|||||
|
2022
Q1 | $65.6M | Sell |
|
|||||
|
2021
Q4 | $99.5M | Buy |
|
|||||
|
2021
Q3 | $97.6M | Buy |
|
|||||
|
2021
Q2 | $60.4M | Buy |
|
|||||
|
2021
Q1 | $45.5M | Sell |
|
|||||
|
2020
Q4 | $50.8M | Buy |
|
|||||
|
2020
Q3 | $44.2M | Buy |
|
|||||
|
2020
Q2 | $37.5M | Buy |
|
|||||
|
2020
Q1 | $23.2M | Buy |
|
|||||
|
2019
Q4 | $17.3M | Buy |
|
|||||
|
2019
Q3 | $9.4M | Sell |
|
|||||
|
2019
Q2 | $13.9M | Sell |
|
|||||
|
2019
Q1 | $13.4M | Buy |
|
|||||
|
2018
Q4 | $7.22M | Buy |
|
|||||
|
2018
Q3 | $4.11M | Buy |
|
|||||
|
2018
Q2 | $1.75M | Buy |
|
|||||
|
2018
Q1 | $1.18M | Buy |
|
|||||
|
2017
Q4 | $519K | Sell |
|
|||||
|
2017
Q3 | $4.98M | Buy |
|
|||||
|
2017
Q2 | $1.38M | Sell |
|
|||||
|
2017
Q1 | $1.72M | Buy |
|
|||||
|
2016
Q4 | $1.09M | Sell |
|
|||||
|
2016
Q3 | $1.83M | Buy |
|
|||||
|
2016
Q2 | $1.41M | Buy |
|
|||||
|
2016
Q1 | $541K | Sell |
|
|||||
|
2015
Q4 | $2.23M | Sell |
|
|||||
|
2015
Q3 | $2.86M | Buy |
|
|||||
|
2015
Q2 | $1.91M | Buy |
|
|||||
|
2015
Q1 | $1.46M | Buy |
|
|||||
|
2014
Q4 | $895K | Buy |
|